Summary
Most laxatives, if used intermittently in the absence of contraindications, are relatively safe. Bulking agents may diminish absorption of some minerals and drugs, but this is not usually clinically significant. Ispaghula can cause serious allergic reactions. The chronic ingestion of stimulant laxatives has been blamed for the development of the ‘cathartic colon’, but there are no definitive studies which have demonstrated this. Dantron (danthron) preparations should only be used in older patients and the terminally ill because of the risk of hepatotoxicity with this drug. Oral oxyphenisatine should no longer be used. Senna would appear to be the stimulant laxative of choice during pregnancy and lactation. Bisacodyl is the polyphenolic derivative of choice. Lactulose, sorbitol and lactilol rarely cause significant adverse effects. Magnesium salt laxatives and phosphate enemas can cause serious metabolic disturbances in babies and young children. Liquid paraffin is contraindicated if there is any risk of aspiration. Interference with the absorption of fat soluble vitamins would not appear to be clinically significant. Docusate sodium may potentiate the hepatotoxicity of other drugs, but reports of this are rare. The role of cisapride in constipation has not been established.
Antidiarrhoeal drugs are second line drugs whose use is aimed at minimising inconvenience and discomfort. No antidiarrhoeals can be recommended for children under 4 years of age. Loperamide is the drug of choice in older children and adults. The atropine component of diphenoxylate/atropine combinations can cause significant adverse effects. Bismuth salicylate is an inconvenient treatment for travellerss’ diarrhoea as large frequent doses of the liquid formulation are needed. Some bismuth can be absorbed and there is the potential to cause encephalopathy. Octreotide, methysergide and cholestyramine have a role for specific causes of diarrhoea only. Octreotide is effective in high output states from the small or large bowel, with few adverse effects. Clonidine and lidamidine may have a role in the treatment of chronic diabetic diarrhoea. The role of lidamidine in nondiabetic chronic diarrhoea has not been established.
Similar content being viewed by others
References
Abramowiecz M (Ed.). Safety of stool softeners. Medical Letter on Drugs and Therapeutics 19: 45–46, 1977
Alestig K, Trollfors B, Stenqvist K. Acute non-specific diarrhoea. Studies on the use of charcoal, kaolin-pectin and diphenoxylate. Practitioner 222: 859–860, 1979
Alison LH, Bulugahapitiya D. Laxative induced magnesium poisoning in a 6 week old infant. British Medical Journal 300: 125, 1990
Allen MD, Greenblatt DJ, Harmatz JS, Smith TW. Effect of magnesium-aluminium hydroxide and kaolin-pectin on absorption of digoxin from tablets and capsules. Journal of Clinical Pharmacology 21: 26–30, 1981
Allison MC, Sercombe J, Pounder RE. A double-blind crossover comparison of lidamidine, loperamide and placebo for the control of chronic diarrhoeas. Alimentary Pharmacology and Therapeutics 2: 347–351, 1988
Angelides A, Fitzgerald JF. Pharmacologic advances in the treatment of gastrointestinal diseases. Pediatric Clinics of North America 28: 95–112, 1981
Armstrong RD, Crisp AJ, Grahame R, Woolf DL. Hypertrophie osteoarthropathy and purgative abuse. British Medical Journal 282: 1836, 1981
Ashton MR, Sutton D, Nielsen M. Severe magnesium toxicity after magnesium sulphate enema in a chronically constipated child. British Medical Journal 300: 541, 1990
Aucamp AK, Achtebergh van SM, Theron E. Potential hazard of magnesium sulphate administration. Lancet 2: 1057, 1981
Baldwin WF. Clinical study of senna administration to nursing mothers: assessment of effects on infant bowel habits. Canadian Medical Association Journal 89: 566–568, 1963
Bardy J-D, Malo J-L, Sequin P, Ghezzo H, Desjardins J, et al. Occupational asthma and IgE sensitization in a pharmaceutical company processing psyllium. American Review of Respiratory Diseases 135: 1033–1038, 1987
Barker P, Hanning C, Trotter T. A study of the effect of picolax on body weight, cardiovascular variables and haemoglobin concentration. Annals of the Royal College of Surgeons of England 74: 318–319, 1992
Barrett KE, Dharmsathaphorn K. Pharmacological aspects of therapy in inflammatory bowel diseases: antidiarrheal agents. Journal of Clinical Gastroenterology 10: 57–63, 1988
Barth JH, Reshad H, Darley CR, Gibson JR. A cutaneous complication of dorbanex therapy. Clinical and Experimental Dermatology 9: 95–96, 1984
Bateman DN, Smith JM. A policy for laxatives. British Medical Journal 298: 188, 1989
Bateman DN. Adverse reactions to gastrointestinal drugs. Update 43: 707–712, 1991
Bell AM. Colonic perforation with a phosphate enema. Journal of the Royal Society of Medicine 83: 54–55, 1990
Bennett JR. Can Fybogel sachets (ispaghula husk) be taken indefinitely? British Medical Journal 293: 1222, 1986
Bernier J-J, Ls’Hirondel Ch, Bretagne J-F. Cell loss under laxatives in human jejunum. Abstract. Gastroenterology 76: 1099A, 1979
Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 337: 372–373, 1991
Bhutta TI, Tahir KI. Loperamide poisoning in children. Lancet 335: 363, 1990
Binder HJ, Dobbins JW, Whiting DS. Evidence against importance of altered mucosal permeability in ricinoleic acid induced fluid secretion. Abstract. Gastroenterology 72: 1029A, 1977
Binder HJ, Donowitz M. A new look at laxative action. Gastroenterology 69: 1001–1005, 1975
Bingham E. Carcinogenicity of mineral oils. Annals of the New York Academy of Sciences 534: 452–458, 1988
Bockus HL, Willard JH, Bank J. Melanosis coli. Journal of the American Medical Association 101: 1–6, 1933
Boulos PB, Karamanolis DG, Salmon PR, Clark CG. A rapid bowel preparation without colonic washout for colonoscopy. Coloproctology 84: 158–159, 1984
Bowyer RC, Urquhart J. Faecal peritonitis induced by picolax. British Medical Journal 295: 1413, 1987
Bradshaw MJ, Harvey RF. Antidiarrhoeal agents: clinical pharmacology and therapeutic use. Drugs 24: 440–451, 1982
British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, London, 1992
Brown AT, Campbell WAB. Hazards of hypertonic magnesium enema therapy. Archives of Disease in Childhood 53: 920, 1978
Brown DD, Juhl RP. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. New England Journal of Medicine 295: 1034–1037, 1976
Buckley P, Larkin C, Os’Callaghan E. Psychosis following use of proprietary antidiarrhoeal medicines. British Journal of Psychiatry 157: 758–759, 1990
Casdorph HR. Safe uses of cholestyramine. Annals of Internal Medicine 72: 759–760, 1970
Chow CB, Li SH, Leung NK. Loperamide associated necrotising enterocolitis. Acta Paediatrica Scandinavica 75: 1034–1036, 1986
Claeson ME, Clements ML. Ridding the world of hydroxyquinolones. British Medical Journal 299: 527–528, 1989
Costello AMdeL, Bhutta TI. Antidiarrhoeal drugs for acute diarrhoea in children. None work, and many may be dangerous. British Medical Journal 304: 1–2, 1992
Connell AM, Hilton C, Irvine G, Lennard-Jones JE, Misiewicz JJ. Variation of bowel habit in two population samples. British Medical Journal 2: 1095–1099, 1965
Courtney SP, Wightman JAK. Urethral calculi caused by cholestyramine. British Journal of Urology 68: 654, 1991
Cox NH, Vickers CFH. A cutaneous complication of dorbanex therapy. Correspondence. Clinical and Experimental Dermatology 9: 624, 1984
Davies RF, Eichner JM, Bleyer WA, Okamoto G. Hypocalcaemia, hyperphosphataemia, and dehydration following a single hypertonic phosphate enema. Journal of Pediatrics 90: 484–485, 1977
Dodson ME. Picolax bowel preparation. British Journal of Anaesthesia 66: 664, 1991
Donowitz M, Binder HJ. Dioctyl sodium sulfosuccinate (DSS) stimulates large intestinal water and electrolyte secretion: mechanism of laxative action? Abstract. Gastroenterology 66: 838A, 1974
Douthwaite AH, Goulding R. Action of senna. British Medical Journal 14: 1414–1415, 1957
Dudl RJ, Forsythe AB, Ziegler MG, Os’Dorisio TM. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. American Journal of Medicine 83: 584–588, 1987
Dufour P, Gendre. Long term mucosal alterations by sennosides and related compounds. Pharmacology 36(Suppl. 1): 194–202, 1988
Dwyer JT, Goldin B, Gorbach S, Patterson J. Dietary fiber and fiber supplements in the therapy of gastrointestinal disorders. Journal of the American Medical Association 69: 51–62, 1978
Eastwood MA, Passmore R. Dietary fibre. Lancet 2: 202–205, 1983
Editorial. In Dialogue on diarrhoea, No. 43, pp. 4-5, AHRTAG, London, 1990
Editorial. Laxative jaundice. British Medical Journal 1: 325, 1972
Editorial. Trifyba — an improved bulk laxative? Drug and Therapeutics Bulletin 30: 63-64, 1992
Elkington SE. Progress report. Lactulose. Gut 11: 1043–1048, 1970
Elliot D, Glover GR. Large bowel perforation due to excessive bran ingestion. British Journal of Clinical Practice 37: 32–33, 1983
Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with Clonidine. Annals of Internal Medicine 102: 197–199, 1985
Fioramonti J, Bueno L. Mechanisms of action of laxatives. In Kamm & Lennard-Jones (Eds) Gastrointestinal transit, pp. 187–194, Wrightson Biomedical Publishing Ltd, Petersfield, 1991
FitzGerald O, Redmond J. Anthraquinone induced clubbing associated with laxative abuse. Irish Journal of Medical Sciences 152: 246–247, 1985
Freese B, Medawar C, Herxheimer A. No more loperamide for infants. Lancet 2: 816–817, 1981
Friedman LS. Somatostatin therapy for Aids diarrhea: muddy waters. Gastroenterology 101: 1446–1447, 1991
Frier BM, Scott RDM. Hypertrophic osteoarthropathy and purgative abuse. British Medical Journal 283: 439, 1981
Gaginella TS, Chadwick VS, Debongnie JC, Lewis JC, Phillips SF. Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. Gastroenterology 73: 95–101, 1977
Garcia-Webb P, Bhagat C, Oh T, Hart G, Thompson W. Hypermagnesaemia and hypophosphataemia after ingestion of magnesium sulphate. British Medical Journal 288: 759, 1984
Garrett JM, Sauer WG, Moertel CG. Colonie motility in ulcerative colitis after opiate administration. Gastroenterology 53: 93–100, 1967
Gascoigne EW, Reyntjens A, Huijghebaert S. World-wide experience with loperamide in acute diarrhoea. In Dupont HL (Ed.) Acute infectious diarrhoea: role of drug therapy, Janssen Pharmaceutical Ltd, Wantage, 1987
German K, Chandiramani VJ, Stephenson TP. A study of the effect of Picolax on body weight, cardiovascular variables and haemoglobin concentration. Annals of the Royal College of Surgeons of England 75: 70, 1993
Gillespie BF, Rathbun FJ. Adverse effects of psyllium. Canadian Medical Association Journal 146: 16–17, 1992
Gilman AG, Rall TW, Nies AS, Taylor P. (Eds). Goodman and Gilmanss’ The pharmacological basis of therapeutics, Pergamon Press, New York, 1990
Gjone E, Blomhoff JP, Ritland S, Elgio K, Husby G. Laxative-induced chronic liver disease. Scandinavian Journal of Gastroenterology 7: 395–402, 1972
Godding EW. Hazards of multilaxative mixtures. British Medical Journal 1: 838, 1976a
Godding EW. Therapeutics of laxative agents with special reference to the anthraquinones. Pharmacology 14(Suppl.): 78–101, 1976b
Goff JS. Diabetic diarrhea and lidamidine. Annals of Internal Medicine 101: 874–875, 1984
Gorbach SL. Bismuth therapy in gastrointestinal diseases. Gastroenterology 99: 863–875, 1990
Gorden P, Comi RJ, Maton PN, Go VLW. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormonesecreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Annals of Internal Medicine 110: 35–50, 1989
Grace R, Hale M. Faecal peritonitis induced by picolax. British Medical Journal 295: 1413, 1987
Greenhalf JO, Leonard HSD. Laxatives in the treatment of constipation in pregnant and breast-feeding mothers. Practitioner 210: 259–263, 1973
Gussin RZ. Withdrawal of loperamide drops. Lancet 335: 1603–1604, 1990
Harvey RF, Read AE. Saline purgatives. Lancet 2: 185–187, 1973
Hasking GJ, Duggan JM. Encephalopathy from bismuth subsalicylate. Medical Journal of Australia 10: 167, 1982
Heaton KW, Leaver JV, Barnard D. Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea. Gastroenterology 62: 642–646, 1972
Hendrickse RG, Woolridge MAW, Russell A. Loperamide in acute diarrhoea in childhood: results of a double blind, placebo controlled multicentre clinical trial. British Medical Journal 289: 1263–1267, 1984
Honig PJ, Holtzapple PG. Hypocalcemic tetany following hypertonic phosphate enemas. Clinical Pediatrics 678-679, 1975
Hool GJ, Bokey EL, Pheils MT. Enema-nozzle injury of the rectum. Medical Journal of Australia 1: 364–365, 1980
Hoyle CHV. Effect of long-term treatment with senna on neuromuscular transmission in the large intestine of the rat. In Kamm & Lennard-Jones (Eds) Gastrointestinal transit, pp. 195–208, Wrightson Biomédical Publishing Ltd, Petersfield, 1991
Hughes K, Mann S, Cooke MBD, James WB. A new oral bowel evacuant (picolax) for colon cleansing. Clinical Radiology 34: 75–77, 1983
Hughes S. Acute secretory diarrhoeas. Drugs 26: 80–90, 1983
Hughes S. Antimotility drugs in the treatment of acute diarrhoea. Biochemical Society Transactions 12 (604th Meeting): 202–205, 1984
Jenkins JA, Jenkins AL. The clinical implications of dietary fiber. Advances in Nutritional Research 6: 169–202, 1984
Johanson JF, Sonnenberg A, Koch TR. Clinical epidemiology of chronic constipation. Journal of Clinical Gastroenterology 11: 525–536, 1989
Kachel G, Ruppin H, Hagel J, Barina W, Meinhardt M, et al. Human intestinal motor activity and transport: effects of a synthetic opiate. Gastroenterology 90: 85–93, 1986
Karaus M, Sarna SK, Ammon HV, Weinbeck M. Effects of oral laxatives on colonic motor complexes in dogs. Gut 28: 1112–1119, 1987
Kaupke C, Sprague T, Gitnick GL. Hypernatremia after administration of lactulose. Annals of Internal Medicine 86: 745–746, 1977
Kendall AC. Fatal case of encephalitis after Phenolphthalein ingestion. British Medical Journal 2: 1461–1462, 1954
Khan MA, Hasan SB. Drugs and diarrhoea. Journal of the Indian Medical Association 87: 125–126, 1989
Krishnamurthy S, Schuffler MD, Rohrmann CA, Pope CE. Severe idiopathic constipation is associated with a distinctive abnormality of the colonie myenteric plexus. Gastroenterology 88: 26–34, 1985
Kronborg IJ, Howard A. Diarrhoea: causes and specific treatment. Drugs 21: 62–68, 1981
Kune GA, Kune S, Field B, Watson LF. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer. Diseases of the Colon and Rectum 31: 507–512, 1988
Kutt E, Hall MJ, Booth A, Virjee J. Barium enemas are a headache. Clinical Radiology 39: 9–10, 1988
Ladefoged K, Christensen KC, Hegnhoj J, Jarnum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 30: 943–949, 1989
Lantner RR, Baltazar RE, Zumerchik P, Tobin MC. Anaphylaxis following ingestion of a psyllium-containing cereal. Journal of the American Medical Association 264: 2534–2536, 1990
Lawrance J, Massoud T, Shatwell W, Mason A, Creasy T, et al. Picolax, hydration and fluid replacement. European Society of Gastrointestinal Radiologists, 2nd Annual Meeting, William Cook Europe Ltd, 1991
Lederle FA, Busch DL, Mattox KM, West MJ, Aske DM. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. American Journal of Medicine 89: 597–601, 1990
Leibach JR, Sninsky CA, Justus PG, Riley RL, Mathias JR. Lidamidine HCL: a new drug for the treatment of diarrheal disorders. Abstract. Gastroenterology 80: A1207, 1981
Leng-Peschlow E. Senna and its rational use. Pharmacology 44(Suppl. 1): 1–52, 1992
Levine D, Goode AW, Wingate DL. Purgative abuse associated with reversible cachexia, hypogammaglobulinaemia, and finger clubbing. Lancet 1: 919–920, 1981
Levitt M, Gessert C, Finberg L. Inorganic phosphate (laxative) poisoning resulting in tetany in an infant. Journal of Pediatrics 82: 479–481, 1973
Lee JR, Ferrando JR. Variables in the preparation of the large intestine for double contrast barium enema examination. Gut 25: 69–72, 1984
Lish PM. Some pharmacologie effects of dioctyl sodium sulfosuccinate on the gastrointestinal tract or the rat. Gastroenterology 41: 580–584, 1961
Loon van FPL, Bennish ML, Speelman P, Butler C. Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh. Gut 30: 492–495, 1989
Lowney ED, Baublis JV, Kreye GM, Harrell ER, McKenzie AR. The scalded skin syndrome in small children. Archives of Dermatology 95: 359–369, 1967
Ludan AC. Current management of acute diarrhoeas. Use and abuse of drug therapy. Drugs 36(Suppl. 4): 18–25, 1988
Ludever JR, Demers LM, Nomides CT. Mechanism of action of castor oil: a biochemical link to the Prostaglandins. Advances in Prostaglandin Thromboxane and Leukotriene Research 8: 1633–1634, 1980
Machado L, Stalenheim G. Respiratory symptoms in ispaghula-allergic nurses after oral challenge with ispaghula suspension. Allergy 39: 65–68, 1984
Machado L, Zetterstrom O, Fagerberg E. Occupational allergy in nurses to a bulk laxative. Allergy 34: 51–55, 1979
Mader TM, Stulting RD. Keratoconjunctivitis sicca caused by diphenoxylate hydrochloride with atropine sulphate (lomotil). American Journal of Ophthalmology 111: 377–378, 1991
Malmquist J, Hulten-Nosslin MB, Ericsson B, Jeppsson J-O. Finger clubbing and aspartylglucosamine excretion in a laxative-abusing patient. Postgraduate Medical Journal 56: 862–864, 1980
Martindale. In Reynolds (Ed.) The extra pharmacopoeia, 1073–1112, 1057–1058, The Pharmaceutical Press, London, 1989
McArthur KE, Anderson DS, Durbin TE, Orloff MJ, Dharmsathaphorn K. Clonidine and lidamidine to inhibit watery diarrhoea in a patient with lung cancer. Annals of Internal Medicine 96: 323–325, 1982
McConnochie K, Edwards JH, Fifield R. Ispaghula sensitization in workers manufacturing a bulk laxative. Clinical and Experimental Allergy 20: 199–202, 1990
McCormick PA, Os’Donoghue D, Brennan N. Diphenoxylate and pancreatitis. Lancet 1: 752, 1985
McDonagh AJG, Singh P, Pilbrow WJ, Yopungs GR. Safety of picolax (sodium picosulphate-magnesium citrate) in inflammatory bowel disease. British Medical Journal 299: 776–777, 1989
Meisel JL, Bergman D, Graney D, Saunders DR, Rubin CE. Human rectal mucosa: protoscopic and morphological changes caused by laxatives. Gastroenterology 72: 1274–1279, 1977
Minton NA, Smith PGD. Loperamide toxicity in a child after a single dose. British Medical Journal 294: 1383, 1987
Moriarty KJ. Laxatives-use and abuse. Gastroenterology in Practice Oct/Nov: 15-24, 1987
Morton AR, Bailie GR. Severe hypermagnesaemia after magnesium sulphate enemas. British Medical Journal 291: 516, 1985
Mori H, Sugie S, Niwa K, Takahashi M, Kawai K. Induction of intestinal tumours in rats by chrysazin. British Journal of Cancer 52: 781–783, 1985
Mori H, Sugie S, Niwak K, Yoshimi N, Tanaka T, Hirono I. Carcinogenicity of chrysazin in large intestine and liver of mice. Japanese Journal of Cancer Research 77: 871–876, 1986
Muhlendahl von KE, Bunjes R, Krienke EG. Loperamide-induced ileus. Lancet 1: 209, 1980
Müller-Lissner SA, Bavarian constipation study group. Treatment of chronic constipation with cisapride and placebo. Gut 28: 1033–1038, 1987
Müller-Lissner S. Nebenwirkungen von Laxantien. Zeitschrift für Gastroenterologie 30: 418–427, 1992
Nakamura GJ, Schneiderman LJ, Klauber MR. Colorectal cancer and bowel habits. Cancer 54: 1475–1477, 1984
Nordstrom M, Melander A, Robertsson E, Steen B. Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients. DrugNutrient Interactions 5: 67–69, 1987
Olm M, Gonzalez FJ, Garcia-Valdecasas JC, Fuster F, Bertran A, et al. Necrotising colitis with perforation in diarrhoic patients treated with loperamide. European Journal of Clinical Pharmacology 40: 415–416, 1991
Outerbridge EW, Papageorgiou A, Stern L. Magnesium sulfate enema in a newborn. Fatal systemic magnesium absorption. Journal of the American Medical Association 224: 1392–1393, 1973
Oxnard SC, Os’Bell J, Grupe WE. Severe tetany in an asotemic child related to a sodium phosphate enema. Pediatrics 53: 105–106, 1974
Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 79: 1272–1275, 1980
Paraskevaides EC. Fatal lipid pneumonia and liquid paraffin. British Journal of Clinical Practice 44: 509–510, 1990
Patel PM, Selby PJ, Deacon J, Chilvers C, McElwain TJ. Anthraquinone laxatives and human cancer: an association in one case. Postgraduate Medical Journal 65: 216–217, 1989
Pattison M, Lee SM. Life-threatening metabolic acidosis from cholestyramine in an infant with renal insufficiency. American Journal of Diseases of Children 141: 479–480, 1987
Pearson AJG, Scheuer PJ, Grainger JM, McIntyre N. Jaundice due to oxyphenisatin. Lancet 1: 994–996, 1971
Perlman BB. Interaction between lithium salts and ispaghula husk. Lancet 335: 416, 1990
Phillips SF. A further look at laxatives. Gastroenterology 70: 464–465, 1976
Phipps RF, Fraser S. Faecal peritonitis induced by picolax. British Medical Journal 295: 1027, 1987
Portnoy BL, Dupont HL, Pruitt D, Abson JA, Rodriguez JT. Antidiarrheal agents in the treatment of acute diarrhea in children. Journal of the American Medical Association 236: 844–846, 1976
Preston DM, Butler MG, Smith B, Lennard-Jones JE. Neuropathology of slow transit constipation. Abstract. Gut 24: A997, 1983
Prior J, White I. Tetany and clubbing in patient who ingested large quantities of senna. Lancet 2: 947, 1978
Qvitzau S, Matzen P, Madsen P. Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium. Scandinavian Journal of Gastroenterology 23: 1237–1240, 1988
Reedy JC, Zwiren GT. Enema-induced hypocalcaemia and hyperphosphatemia leading to cardiac arrest during induction of aneasthesia in an outpatient surgery center. Anesthesiology 59: 578–579, 1983
Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative oxyphenisatin. New England Journal of Medicine 285: 813–820, 1971
Richter WO, Jacob BG, Schwandt P. Interaction between fibre and lovastatin. Lancet 338: 706, 1991
Riemann JF, Schmidt H. Ultrastructural changes in the gut autonomic nervous system following laxative abuse and in other conditions. Scandinavian Journal of Gastroenterology 17(Suppl. 71): 111–124, 1982
Rieman JF, Schenk J, Ehler R, Schmidt H, Koch H. Ultrastructural changes of colonic mucosa in patients with chronic laxative misuse. Acta Hepato-Gastroenterologica 25: 213–218, 1978
Rohack JJ, Mehta BR, Subramanyam K. Hyperphosphatemia and hypocalcemic coma associated with phosphate enema. Southern Medical Journal 78: 1241–1242, 1985
Rohde JE, Cash RA, Guerrant RL, Mahalanabis D, Molla AM, et al. Therapeutic interventions in diarrhea. Diarrhoea and Malnutrition: Interactions, Mechanisms and Interventions, pp. 287–295, Plen Press, New York, 1983
Salim A, Tariq B, Tariq M. Effect of magnesium trisilicate and kaolin-pectin on the bioavailability of trimethoprim. Research Communications in Chemical Pathology and Pharmacology 40: 165–167, 1983
Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Digestive Diseases and Sciences 32: 841–845, 1987
Sarner M. Problems caused by laxatives. Practitioner 216: 661–664, 1976
Saunders DR, Sillery J, Rachmilewitz D. Effect of dioctyl sodium sulfsuccinate on structure and function of rodent and human intestine. Gastroenterology 69: 380–386, 1975
Savin JA. Current causes of fixed drug eruptions. British Journal of Dermatology 83: 546–549, 1970
Scheel PJ, Baughman K, Whelton A, Watson A. Cholestyramine related hyperchloremic metabolic acidosis. Journal of Clinical Pharmacology 31: 860, 1991
Schindler AM. Isolated neonatal hypomagnesaemia associated with maternal overuse of stool softner. Lancet 2: 822, 1984
Schiller LR, Santa Ana CA, Morawski G, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 86: 1475–1480, 1984
Scott RS. Management of constipation in obstetrics: a clinical report on 592 cases. Western Medicine 6: 342–344, 1965
Shelton MG. Standardized senna in the management of constipation in the puerperium. South African Medical Journal 57: 78–80, 1980
Siegers C-P. Anthranoid laxatives and colorectal cancer. Trends in Pharmacological Sciences 13: 229–231, 1992
Siegers C-P, Hertzberg-Lottin E, Otte M, Schneider B. Anthranoid laxative abuse - a risk for colorectal cancer? Gut 34: 1099–1101, 1993
Silk DBA, Gibson JA, Murray CRH. Reversible finger clubbing in a case of purgative abuse. Gastroenterology 68: 790–794, 1975
Smith DF, Smith CC, Douglas JG, Reid TMS, Gould IM. Severe salmonellosis related to oral adminstration of anti-diarrhoeal drugs. Scottish Medical Journal 35: 176–177, 1990
Smith MS, Feldman KW, Furukawa CT. Coma in an infant due to hypertonic sodium phospate medication. Journal of Pediatrics 82: 481–482, 1973
Smith B. Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut 9: 139–143, 1968
Smith B. Pathology of cathartic colon. Proceedings of the Royal Society of Medicine 65: 288–291, 1972
Smith B, Pathologic changes in the colon produced by anthraquinone purgatives. Diseases of the Colon and Rectum 16: 455–458, 1973
Sotos JF, Cutler EA, Finkel MA, Doody D. Hypocalcemic coma following two pediatric phosphate enemas. Pediatrics 60: 305–307, 1977
Souter WA. Bolus obstruction of gut after use of hydrophilic colloid laxatives. British Medical Journal 1: 166–168, 1965
Speare GS. Melanosis coli. American Journal of Surgery 82: 631–637, 1951
Spinrad S, Grosskopf Y, Blum I, Sztern M, Graff E. Treating constipation with phosphate enema: an unnecessary risk. Israel Journal of Medical Sciences 25: 237–238, 1989
Steer HW, Colin-Jones DG. Melanosis coli: studies of the toxic effects of irritant purgatives. Journal of Pathology 115: 199–205, 1975
Steingrub JS, Lopez T, Teres D, Steingart R. Amniotic fluid embolism associated with castor oil ingestion. Critical Care Medicine 16: 642–643, 1988
Taylor TV, Lambert ME, Torrance HB. Value of bile-acid binding agents in post-vagotomy diarrhoea. Lancet 1: 635–636, 1978
Thompson WG. Laxatives: clinical pharmacology and rational use. Drugs 19: 49–58, 1980
Tolman KG, Hammar S, Sannella JJ. Possible hepatotoxicity of doxidan. Annals of Internal Medicine 84: 290–292, 1976
Tremaine WJ. Diarrhea and constipation therapy. Current Opinion in Gastroenterology 8: 60–63, 1992
Umeki S. Does bismuth subnitrate normalize intestinal conditions in patients with chronic diarrhea. Archives of Internal Medicine 148: 2073, 1988
Verbov J. Laxative eruption. Correspondence. Clinical and Experimental Dermatology 9: 435, 1984
Verhaeren EHC, Geboes K, Lemli J. The morphological alterations of guinea pig colonic mucosa following short term administration of high doses of 1-8 dihydroxyanthraquinone. Colo-Proctology 7: 205–208, 1985
Wainscoat JS, Finn R. Possible role of laxatives in analgesic nephropathy. British Medical Journal 4: 697–698, 1974
Walley T, Milson D. Loperamide related toxic megacolon in Clostridium difficile colitis. Postgraduate Medical Journal 66: 582–584, 1990
Ware S. Drugs for diarrhoea in small children. Lancet 1: 252–253, 1977
Watson JS, Ebert WR. Lactulose: a new bowel regulator. Clinical Medicine (July): 24-26, 1969
Weaver LT, Richmond SWJ, Nelson R. Loperamide toxicity in severe protracted diarrhoea. Archives of Diseases in Childhood 58: 568–569, 1983
Weller MPI. Neuropsychiatrie symptoms following bismuth intoxication. Postgraduate Medical Journal 64: 308–310, 1988
Wittoesch JH, Jackman RJ, McDonald JR. Melanosis coli: general review and a study of 887 cases. Diseases of the Colon and Rectum 1: 172–180, 1958
World Health Organisation. Rational use of drugs in the management of acute diarrhoea in children. World Health Organisation, Geneva, 1990
Wright RA. Lactulose-induced megacolon. Gastrointestinal Endoscopy 34: 489–490, 1988
Wynne HA, Edwards C. Laxatives. Pharmaceutical Journal 248: 17–19, 1992
Yam LT, Oropilla SB. Octreotide for diarrhea in amyloidosis. Annals of Internal Medicine 115: 577, 1991
Ziegenhagen DJ, Tewinkel G, Kruis W, Herrmann F. Adding more fluid to wheat bran has no significant effects on intestinal functions of healthy subjects. Journal of Clinical Gastroenterology 13: 525–530, 1991
Zimmerman AL, Gupta JK, Ingegno AP. Pneumatosis coli following treatment with lactulose. New York State Journal of Medicine 79: 1896–1899, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gattuso, J.M., Kamm, M.A. Adverse Effects of Drugs Used in the Management of Constipation and Diarrhoea. Drug-Safety 10, 47–65 (1994). https://doi.org/10.2165/00002018-199410010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199410010-00004